Literature DB >> 20224412

Pelvic node dissection in prostate cancer: extended, limited, or not at all?

Matthew Eric Hyndman1, Jeffrey K Mullins, Christian P Pavlovich.   

Abstract

PURPOSE OF REVIEW: Pelvic lymph node dissection in patients with clinically localized prostate cancer has long been an established part of radical prostatectomy that provides prognostic information in men with locally metastatic disease. However, given downward stage migration over the last 25 years, it is no longer clear that pelvic lymphadenectomy is pertinent for most men diagnosed today. In men in whom it is pertinent, it is unclear how extensive a lymphadenectomy should be performed. RECENT
FINDINGS: Computed tomography and magnetic resonance imaging alone are not accurate for detecting nodal metastases, but new modalities such as magnetic resonance lymphography have great apparent potential. Until these become widely available, pelvic lymph node dissection remains the modality of choice for detecting lymph node metastasis. A variety of predictive nomograms exists to predict lymph node involvement. As a pelvic lymphadenectomy has complications that generally increase with extent of dissection, lymphadenectomy should be limited to patients at an increased risk of nodal metastasis.
SUMMARY: There is good evidence that a pelvic lymph node dissection limited to the external iliac vein nodes is unnecessary in men with low-risk prostate cancer. A standard external iliac and obturator lymph node dissection, with or without extension to hypogastric nodes, makes sense in cases of intermediate and high risk. Harvesting a greater number of lymph nodes adds prognostic and even therapeutic benefit in many cases, including in some men with no obvious nodal metastases.

Entities:  

Mesh:

Year:  2010        PMID: 20224412     DOI: 10.1097/MOU.0b013e328338405d

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  8 in total

1.  Role of lymph node dissection in managing urologic cancers.

Authors:  Tomonori Habuchi
Journal:  Int J Clin Oncol       Date:  2011-04-07       Impact factor: 3.402

2.  Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.

Authors:  Anja M Weidner; Emile N J Th van Lin; Dietmar J Dinter; Tom Rozema; Stefan O Schoenberg; Frederik Wenz; Jelle O Barentsz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

Review 3.  In vivo bio-imaging using chlorotoxin-based conjugates.

Authors:  Mark R Stroud; Stacey J Hansen; James M Olson
Journal:  Curr Pharm Des       Date:  2011-12       Impact factor: 3.116

4.  Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.

Authors:  Hiromichi Iwamura; Shingo Hatakeyama; Takuma Narita; Yusuke Ozaki; Sakae Konishi; Hirotaka Horiguchi; Hirotake Kodama; Yuta Kojima; Naoki Fujita; Teppei Okamoto; Yuki Tobisawa; Tohru Yoneyama; Hayato Yamamoto; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

5.  Is there a relationship between the number of lymph nodes and disease parameters in patients who underwent retropubic prostatectomy.

Authors:  Aslan Demir; Mert Ali Karadağ; Levent Türkeri
Journal:  Int Urol Nephrol       Date:  2014-03-25       Impact factor: 2.370

6.  Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan.

Authors:  Chun-Ming Chang; Kuang-Yung Huang; Ta-Wen Hsu; Yu-Chieh Su; Wei-Zhen Yang; Ting-Chang Chen; Pesus Chou; Ching-Chih Lee
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

7.  Optimizing the management of high-risk, localized prostate cancer.

Authors:  Debasish Sundi; Byong Chang Jeong; Seung Bae Lee; Misop Han
Journal:  Korean J Urol       Date:  2012-12-20

Review 8.  Extended lymph node dissection in robotic radical prostatectomy: Current status.

Authors:  Sameer Chopra; Mehrdad Alemozaffar; Inderbir Gill; Monish Aron
Journal:  Indian J Urol       Date:  2016 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.